Planet Labs PBC (PL) Financials

$5.11 -0.23 (-4.38%)

As of 03:24 PM Eastern

Annual Income Statements for Planet Labs PBC

This table shows Planet Labs PBC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-124	-127	-137	-162	-141	-123
Consolidated Net Income / (Loss)	-124	-127	-137	-162	-141	-123
Net Income / (Loss) Continuing Operations	-124	-127	-137	-162	-141	-123
Total Pre-Tax Income	-124	-126	-135	-161	-140	-121
Total Operating Income	-106	-87	-128	-176	-170	-116
Total Gross Profit	-6.66	26	48	94	113	140
Total Revenue	96	113	131	191	221	244
Operating Revenue	96	113	131	191	221	244
Total Cost of Revenue	102	87	83	97	108	105
Operating Cost of Revenue	102	87	83	97	108	105
Total Operating Expenses	100	113	176	270	283	256
Selling, General & Admin Expense	27	32	57	81	80	77
Marketing Expense	35	37	53	78	86	78
Research & Development Expense	38	44	67	111	116	101
Total Other Income / (Expense), net	-17	-39	-6.96	15	30	-4.61
Interest & Investment Income	-	0.05	0.02	7.67	15	10
Other Income / (Expense), net	1.35	-30	3.48	6.88	15	-15
Income Tax Expense	0.13	1.07	2.11	0.85	0.82	2.46
Basic Earnings per Share	($2.89)	($2.87)	($1.72)	($0.61)	($0.50)	($0.42)
Weighted Average Basic Shares Outstanding	42.86M	44.21M	79.61M	267.13M	279.59M	292.12M
Diluted Earnings per Share	($2.89)	($2.87)	($1.72)	($0.61)	($0.50)	($0.42)
Weighted Average Diluted Shares Outstanding	42.86M	44.21M	79.61M	267.13M	279.59M	292.12M
Weighted Average Basic & Diluted Shares Outstanding	-	-	267.90M	274.97M	290.62M	302.25M

This table shows Planet Labs PBC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-40	-38	-34	-38	-38	-30	-29	-39	-20	-35	-13
Consolidated Net Income / (Loss)	-40	-38	-34	-38	-38	-30	-29	-39	-20	-35	-13
Net Income / (Loss) Continuing Operations	-40	-38	-34	-38	-38	-30	-29	-39	-20	-35	-13
Total Pre-Tax Income	-40	-38	-34	-37	-38	-31	-29	-38	-20	-34	-12
Total Operating Income	-43	-43	-45	-43	-48	-34	-35	-40	-23	-19	-23
Total Gross Profit	25	29	28	26	26	32	32	32	38	38	37
Total Revenue	50	53	53	54	55	59	60	61	61	62	66
Operating Revenue	50	53	53	54	55	59	60	61	61	62	66
Total Cost of Revenue	25	24	25	27	29	26	29	29	24	23	30
Operating Cost of Revenue	25	24	25	27	29	26	29	29	24	23	30
Total Operating Expenses	68	72	73	70	74	66	66	72	60	58	59
Selling, General & Admin Expense	21	20	22	21	20	18	19	21	18	19	20
Marketing Expense	19	20	23	22	21	20	21	24	17	16	16
Research & Development Expense	28	32	28	27	33	28	26	27	25	23	23
Total Other Income / (Expense), net	2.84	4.79	11	5.89	10	3.40	5.72	1.81	2.55	-15	11
Interest & Investment Income	2.85	3.40	4.51	3.80	3.45	3.66	3.11	2.77	2.41	1.97	1.88
Other Income / (Expense), net	-0.02	1.39	6.05	2.09	6.76	-0.26	2.61	-0.97	0.14	-17	9.19
Income Tax Expense	0.44	-0.06	0.31	0.58	0.36	-0.43	0.44	0.90	0.00	1.12	0.93
Basic Earnings per Share	($0.15)	($0.14)	($0.13)	($0.14)	($0.13)	($0.10)	($0.10)	($0.13)	($0.07)	($0.12)	($0.04)
Weighted Average Basic Shares Outstanding	267.95M	267.13M	272.35M	275.05M	284.20M	279.59M	288.27M	290.36M	293.34M	292.12M	300.27M
Diluted Earnings per Share	($0.15)	($0.14)	($0.13)	($0.14)	($0.13)	($0.10)	($0.10)	($0.13)	($0.07)	($0.12)	($0.04)
Weighted Average Diluted Shares Outstanding	267.95M	267.13M	272.35M	275.05M	284.20M	279.59M	288.27M	290.36M	293.34M	292.12M	300.27M
Weighted Average Basic & Diluted Shares Outstanding	272.10M	274.97M	276.03M	285.66M	287.63M	290.62M	290.77M	293.48M	296.71M	302.25M	303.43M

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Change in Cash & Equivalents	-52	49	420	-309	-86	28
Net Cash From Operating Activities	-34	-4.03	-42	-74	-51	-14
Net Cash From Continuing Operating Activities	-34	-4.03	-42	-74	-51	-14
Net Income / (Loss) Continuing Operations	-124	-127	-137	-162	-141	-123
Consolidated Net Income / (Loss)	-124	-127	-137	-162	-141	-123
Depreciation Expense	78	62	45	43	48	46
Non-Cash Adjustments To Reconcile Net Income	17	43	39	69	43	64
Changes in Operating Assets and Liabilities, net	-6.04	15	8.19	-24	-1.26	-0.42
Net Cash From Investing Activities	-27	-31	-25	-242	-34	58
Net Cash From Continuing Investing Activities	-27	-31	-25	-242	-34	58
Purchase of Property, Plant & Equipment	-24	-30	-15	-13	-42	-50
Acquisitions	-2.46	0.00	-9.62	-3.82	-7.54	-5.85
Purchase of Investments	-	0.00	0.00	-280	-189	-140
Sale and/or Maturity of Investments	-	0.00	0.00	55	207	254
Other Investing Activities, net	-0.61	-0.67	-0.60	-0.56	-1.39	-0.30
Net Cash From Financing Activities	8.73	84	489	7.86	-1.60	-16
Net Cash From Continuing Financing Activities	8.73	84	489	7.86	-1.60	-16
Repayment of Debt	-51	-2.59	-67	-0.50	-0.02	-0.74
Issuance of Common Equity	-	-	-	0.00	0.00	1.55
Other Financing Activities, net	0.26	0.54	556	8.36	-1.58	-16
Effect of Exchange Rate Changes	-	-0.31	-1.55	-0.40	0.02	-0.20
Cash Income Taxes Paid	0.00	1.08	0.88	3.10	-0.16	1.80

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Net Change in Cash & Equivalents	-63	-17	-42	-22	-4.77	-18	24	41	-17	-20	16
Net Cash From Operating Activities	-30	-15	-31	9.60	-23	-6.84	-4.30	-7.86	4.08	-6.30	17
Net Cash From Continuing Operating Activities	-30	-15	-31	9.60	-23	-6.84	-4.30	-7.86	4.08	-6.30	17
Net Income / (Loss) Continuing Operations	-40	-38	-34	-38	-38	-30	-29	-39	-20	-35	-13
Consolidated Net Income / (Loss)	-40	-38	-34	-38	-38	-30	-29	-39	-20	-35	-13
Depreciation Expense	11	9.33	10	12	14	12	13	13	10	9.27	11
Non-Cash Adjustments To Reconcile Net Income	19	15	9.41	15	5.77	13	12	12	12	28	2.16
Changes in Operating Assets and Liabilities, net	-20	-0.83	-16	20	-4.26	-1.17	0.35	5.50	2.41	-8.67	17
Net Cash From Investing Activities	-34	-4.79	-13	-32	20	-9.55	30	51	-11	-13	1.74
Net Cash From Continuing Investing Activities	-34	-4.79	-13	-32	20	-9.55	30	51	-11	-13	1.74
Purchase of Property, Plant & Equipment	-2.97	-2.02	-7.08	-17	-8.65	-10	-11	-17	-8.86	-13	-9.34
Acquisitions	-	-3.82	0.00	-	-7.54	-	-5.09	-0.27	-0.27	-0.23	-0.62
Purchase of Investments	-44	-41	-35	-92	-38	-23	-28	-54	-24	-35	0.00
Sale and/or Maturity of Investments	13	42	30	78	75	24	75	122	22	35	12
Other Investing Activities, net	-0.12	-0.15	-0.28	-0.37	-0.30	-0.45	-0.30	-	-	-	0.00
Net Cash From Financing Activities	2.33	1.48	1.40	0.19	-1.95	-1.24	-2.38	-2.73	-10	-0.23	-9.16
Net Cash From Continuing Financing Activities	2.33	1.48	1.40	0.19	-1.95	-1.24	-2.38	-2.73	-10	-0.23	-9.16
Repayment of Debt	-	-0.63	0.00	-0.02	-	-	-0.38	0.04	-0.27	-0.13	-2.38
Issuance of Common Equity	-	-	-	-	-	-	0.00	-	0.38	0.47	0.35
Other Financing Activities, net	2.33	1.78	1.40	0.21	-1.95	-1.24	-2.00	-3.47	-10	-0.57	-7.12
Effect of Exchange Rate Changes	-0.66	1.38	0.18	-0.02	-0.22	0.08	-0.28	0.24	0.11	-0.28	5.68

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Total Assets	0.09	399	821	753	702	634
Total Current Assets	0.00	125	552	476	370	302
Cash & Equivalents	0.00	71	491	182	84	118
Restricted Cash	-	-	-	0.53	8.36	6.60
Short-Term Investments	-	-	0.00	227	215	104
Accounts Receivable	-	47	44	39	43	56
Prepaid Expenses	0.00	7.13	16	27	20	18
Plant, Property, & Equipment, net	0.00	160	133	108	113	122
Total Noncurrent Assets	0.09	114	137	169	218	210
Goodwill	-	88	103	113	136	136
Intangible Assets	-	18	25	26	47	46
Other Noncurrent Operating Assets	0.09	7.97	8.46	30	25	22
Other Noncurrent Nonoperating Assets	-	-	-	-	9.97	5.35
Total Liabilities & Shareholders' Equity	0.09	399	821	753	702	634
Total Liabilities	0.06	292	173	177	184	193
Total Current Liabilities	0.06	109	132	122	137	142
Accounts Payable	0.01	1.45	2.85	6.90	2.60	2.60
Accrued Expenses	0.05	30	49	46	45	43
Current Deferred Revenue	-	58	64	52	72	82
Other Current Liabilities	-	11	16	17	17	15
Total Noncurrent Liabilities	0.00	183	41	54	47	50
Noncurrent Deferred Revenue	-	18	4.38	2.88	5.29	11
Other Noncurrent Operating Liabilities	0.00	9.26	37	51	42	39
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	0.02	108	648	576	518	441
Total Preferred & Common Equity	0.02	108	648	576	518	441
Total Common Equity	0.02	107	648	576	518	441
Common Stock	0.03	746	1,423	1,513	1,596	1,645
Retained Earnings	-0.00	-640	-777	-939	-1,080	-1,203
Accumulated Other Comprehensive Income / (Loss)	-	1.77	2.10	2.27	1.59	-1.10

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	4/30/2022	7/31/2022	10/31/2022	4/30/2023	7/31/2023	10/31/2023	4/30/2024	7/31/2024	10/31/2024	4/30/2025
Total Assets	796	768	747	723	720	714	675	658	631	658
Total Current Assets	527	504	481	435	428	388	346	327	302	325
Cash & Equivalents	484	262	199	141	119	102	107	148	139	133
Restricted Cash	-	-	-	-	-	7.88	8.80	8.80	6.53	6.61
Short-Term Investments	-	196	226	235	249	213	168	101	103	93
Accounts Receivable	25	26	29	39	40	45	39	44	39	75
Prepaid Expenses	18	20	26	19	20	20	23	25	14	17
Plant, Property, & Equipment, net	125	121	115	118	120	114	111	113	117	122
Total Noncurrent Assets	143	143	151	171	172	212	217	218	212	211
Goodwill	103	103	103	113	113	136	137	137	137	138
Intangible Assets	25	24	24	26	28	41	47	48	47	48
Other Noncurrent Operating Assets	15	15	24	26	26	24	23	24	23	20
Other Noncurrent Nonoperating Assets	-	-	-	5.66	5.71	10	9.56	9.54	4.44	5.53
Total Liabilities & Shareholders' Equity	796	768	747	723	720	714	675	658	631	658
Total Liabilities	165	154	153	164	181	180	174	185	166	214
Total Current Liabilities	129	122	110	112	116	131	126	140	129	155
Accounts Payable	3.17	2.19	2.56	15	3.83	4.59	3.13	2.39	3.57	4.10
Accrued Expenses	43	48	43	34	38	42	43	57	44	29
Current Deferred Revenue	61	52	48	45	57	67	64	65	66	108
Other Current Liabilities	22	20	17	18	18	17	16	16	15	13
Total Noncurrent Liabilities	36	32	43	52	65	49	48	45	37	59
Noncurrent Deferred Revenue	0.00	0.00	0.00	2.47	18	7.76	13	12	11	30
Other Noncurrent Operating Liabilities	36	32	43	50	46	41	35	33	26	29
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	631	614	594	559	540	534	500	473	465	445
Total Preferred & Common Equity	631	614	594	559	540	534	500	473	465	445
Total Common Equity	631	614	594	559	540	534	500	473	465	445
Common Stock	1,450	1,472	1,495	1,531	1,550	1,584	1,609	1,620	1,631	1,657
Retained Earnings	-822	-861	-901	-974	-1,012	-1,050	-1,109	-1,148	-1,168	-1,216
Accumulated Other Comprehensive Income / (Loss)	2.27	2.72	0.94	1.68	1.34	-0.24	0.55	1.25	1.35	3.69

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	18.21%	15.94%	45.76%	15.39%	10.72%
EBITDA Growth	0.00%	-100.66%	-46.89%	-63.16%	14.34%	20.58%
EBIT Growth	0.00%	-11.61%	-6.19%	-35.50%	8.11%	15.55%
NOPAT Growth	0.00%	17.86%	-46.44%	-37.19%	3.37%	31.59%
Net Income Growth	0.00%	-2.74%	-7.88%	-18.12%	13.25%	12.32%
EPS Growth	0.00%	0.69%	40.07%	64.53%	18.03%	16.00%
Operating Cash Flow Growth	0.00%	88.05%	-948.20%	-75.15%	31.41%	71.66%
Free Cash Flow Firm Growth	0.00%	0.00%	82.04%	-181.89%	-15.48%	42.55%
Invested Capital Growth	0.00%	848,137.29%	-21.33%	5.93%	20.36%	3.23%
Revenue Q/Q Growth	0.00%	0.00%	-36.68%	9.02%	2.74%	1.12%
EBITDA Q/Q Growth	0.00%	0.00%	56.89%	-0.94%	8.04%	-5.15%
EBIT Q/Q Growth	0.00%	0.00%	30.17%	0.40%	4.39%	-1.43%
NOPAT Q/Q Growth	0.00%	0.00%	15.11%	7.63%	4.91%	11.14%
Net Income Q/Q Growth	0.00%	0.00%	30.34%	4.78%	5.23%	-4.29%
EPS Q/Q Growth	0.00%	0.00%	61.44%	-190.48%	7.41%	-5.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-95.60%	7.94%	13.59%	3.63%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	56.19%	2.43%	14.28%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-1.22%	0.14%	-1.96%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	-6.95%	22.78%	36.75%	49.15%	51.18%	57.18%
EBITDA Margin	-27.25%	-46.26%	-58.61%	-65.60%	-48.70%	-34.93%
Operating Margin	-111.20%	-77.27%	-97.59%	-91.85%	-76.91%	-47.52%
EBIT Margin	-109.79%	-103.66%	-94.94%	-88.25%	-70.28%	-53.61%
Profit (Net Income) Margin	-129.22%	-112.31%	-104.51%	-84.69%	-63.67%	-50.42%
Tax Burden Percent	100.11%	100.85%	101.56%	100.53%	100.58%	102.04%
Interest Burden Percent	117.58%	107.43%	108.38%	95.45%	90.06%	92.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-315,771.19%	-61.15%	-50.12%	-75.84%	-64.65%	-39.84%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-203.35%	-26.26%	-67.17%	-58.68%	-24.64%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-175.25%	13.83%	49.38%	38.96%	14.16%
Return on Equity (ROE)	0.00%	-236.39%	-36.29%	-26.46%	-25.68%	-25.68%
Cash Return on Invested Capital (CROIC)	0.00%	-261.10%	-26.24%	-81.60%	-83.13%	-43.02%
Operating Return on Assets (OROA)	-122,576.09%	-58.74%	-20.41%	-21.45%	-21.32%	-19.61%
Return on Assets (ROA)	-144,272.89%	-63.65%	-22.47%	-20.58%	-19.32%	-18.45%
Return on Common Equity (ROCE)	0.00%	-236.37%	-36.29%	-26.46%	-25.68%	-25.68%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-118.22%	-21.15%	-28.11%	-27.12%	-27.92%
Net Operating Profit after Tax (NOPAT)	-75	-61	-90	-123	-119	-81
NOPAT Margin	-77.84%	-54.09%	-68.32%	-64.30%	-53.84%	-33.27%
Net Nonoperating Expense Percent (NNEP)	0.00%	142.21%	-23.86%	-8.66%	-5.97%	-15.21%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-21.35%	-22.94%	-18.42%
Cost of Revenue to Revenue	106.95%	77.22%	63.25%	50.85%	48.82%	42.82%
SG&A Expenses to Revenue	28.22%	28.40%	43.19%	42.22%	36.27%	31.57%
R&D to Revenue	39.56%	38.73%	50.82%	57.99%	52.71%	41.34%
Operating Expenses to Revenue	104.25%	100.05%	134.35%	141.01%	128.09%	104.70%
Earnings before Interest and Taxes (EBIT)	-105	-117	-125	-169	-155	-131
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-26	-52	-77	-125	-107	-85
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	12,711.86	2.79	0.41	2.34	1.25	4.10
Price to Tangible Book Value (P/TBV)	12,711.86	208.62	0.51	3.08	1.94	7.00
Price to Revenue (P/Rev)	3.13	2.65	2.00	7.04	2.95	7.41
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12,711.86	1.96	0.00	5.62	1.71	7.63
Enterprise Value to Revenue (EV/Rev)	3.13	3.47	0.00	4.90	1.55	6.47
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	1.52	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	1.45	0.00	0.00	0.00	0.00
Financial Leverage	0.00	0.86	-0.53	-0.74	-0.66	-0.57
Leverage Ratio	3.63	3.71	1.62	1.29	1.33	1.39
Compound Leverage Factor	4.27	3.99	1.75	1.23	1.20	1.28
Debt to Total Capital	0.00%	60.38%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	3.04%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	57.34%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	39.61%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	-3.13	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	-1.77	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	-2.97	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	-2.68	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	-1.51	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	-2.54	0.00	0.00	0.00	0.00
Altman Z-Score	-33.23	-2.26	-0.14	2.91	-0.05	2.99
Noncontrolling Interest Sharing Ratio	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.15	4.18	3.89	2.71	2.13
Quick Ratio	0.00	1.09	4.05	3.66	2.50	1.96
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-261	-47	-132	-153	-88
Operating Cash Flow to CapEx	-139.77%	-13.37%	-282.71%	-579.41%	-119.57%	-28.97%
Free Cash Flow to Firm to Interest Expense	0.00	-29.79	-4.49	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-1.82	-0.46	-4.03	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-3.13	-3.89	-5.46	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	1,116.45	0.57	0.22	0.24	0.30	0.37
Accounts Receivable Turnover	0.00	0.00	2.87	4.59	5.37	4.93
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.90	1.58	1.99	2.08
Accounts Payable Turnover	9,524.93	119.97	38.63	19.95	22.68	40.20
Days Sales Outstanding (DSO)	0.00	0.00	127.24	79.51	68.03	74.05
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.04	3.04	9.45	18.30	16.09	9.08
Cash Conversion Cycle (CCC)	-0.04	-3.04	117.80	61.21	51.94	64.98
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.02	200	157	167	201	207
Invested Capital Turnover	4,056.61	1.13	0.73	1.18	1.20	1.20
Increase / (Decrease) in Invested Capital	0.00	200	-43	9.33	34	6.49
Enterprise Value (EV)	300	393	-228	938	343	1,581
Market Capitalization	300	300	263	1,347	650	1,810
Book Value per Share	$0.00	$2.43	$15.03	$2.12	$1.80	$1.49
Tangible Book Value per Share	$0.00	$0.03	$12.06	$1.61	$1.16	$0.87
Total Capital	0.02	271	648	576	518	441
Total Debt	0.00	164	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	156	0.00	0.00	0.00	0.00
Net Debt	0.00	93	-491	-409	-307	-229
Capital Expenditures (CapEx)	24	30	15	13	42	50
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.06	-46	-71	-56	-74	-69
Debt-free Net Working Capital (DFNWC)	-0.06	25	419	353	234	160
Net Working Capital (NWC)	-0.06	17	419	353	234	160
Net Nonoperating Expense (NNE)	49	66	47	39	22	42
Net Nonoperating Obligations (NNO)	0.00	93	-491	-409	-317	-234
Total Depreciation and Amortization (D&A)	79	65	48	43	48	46
Debt-free, Cash-free Net Working Capital to Revenue	-0.06%	-40.94%	-54.33%	-29.22%	-33.42%	-28.04%
Debt-free Net Working Capital to Revenue	-0.06%	21.96%	319.70%	184.78%	105.80%	65.54%
Net Working Capital to Revenue	-0.06%	14.68%	319.70%	184.78%	105.80%	65.54%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($1.72)	($0.61)	($0.50)	($0.42)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	79.61M	267.13M	279.59M	292.12M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($1.72)	($0.61)	($0.50)	($0.42)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	79.61M	267.13M	279.59M	292.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	267.90M	274.97M	290.62M	302.25M
Normalized Net Operating Profit after Tax (NOPAT)	-75	-61	-90	-123	-119	-81
Normalized NOPAT Margin	-77.84%	-54.09%	-68.32%	-64.30%	-53.84%	-33.27%
Pre Tax Income Margin	-129.09%	-111.37%	-102.90%	-84.24%	-63.30%	-49.41%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-5.69	-13.37	-11.91	0.00	0.00	0.00
NOPAT to Interest Expense	-4.03	-6.98	-8.57	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-6.99	-16.80	-13.33	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-5.34	-10.41	-9.99	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	56.80%	42.61%	31.34%	10.96%	11.42%	11.09%	14.68%	13.64%	10.63%	4.59%	9.64%
EBITDA Growth	-20.66%	-4.82%	12.72%	0.22%	13.80%	29.39%	33.60%	5.64%	55.03%	-18.52%	86.73%
EBIT Growth	-10.66%	1.62%	12.49%	-1.25%	3.65%	17.24%	17.30%	1.59%	45.32%	-5.40%	57.49%
NOPAT Growth	-50.58%	25.38%	6.33%	-1.50%	-12.26%	20.55%	22.65%	8.56%	52.76%	42.90%	34.13%
Net Income Growth	3.14%	17.67%	22.35%	3.93%	5.55%	20.49%	14.95%	-1.82%	47.16%	-16.85%	56.89%
EPS Growth	82.95%	-153.85%	23.53%	6.67%	13.33%	28.57%	23.08%	7.14%	46.15%	-20.00%	60.00%
Operating Cash Flow Growth	-138.45%	30.10%	-368.33%	143.09%	24.56%	53.85%	85.96%	-181.88%	117.82%	7.93%	503.68%
Free Cash Flow Firm Growth	-172.91%	-1,576.07%	65.16%	78.25%	67.23%	-47.14%	15.21%	-66.13%	58.94%	65.27%	69.58%
Invested Capital Growth	0.00%	5.93%	21.40%	6.49%	18.73%	20.36%	16.26%	23.75%	5.44%	3.23%	0.10%
Revenue Q/Q Growth	2.59%	6.58%	-0.51%	2.01%	3.01%	6.27%	2.70%	1.08%	0.28%	0.47%	7.65%
EBITDA Q/Q Growth	-9.51%	-0.31%	11.17%	-2.25%	5.39%	17.83%	16.46%	-45.30%	54.91%	-116.55%	90.65%
EBIT Q/Q Growth	-4.83%	3.17%	6.43%	-6.60%	0.25%	16.83%	6.49%	-26.86%	44.58%	-60.32%	62.29%
NOPAT Q/Q Growth	0.02%	-0.13%	-4.69%	3.16%	-10.58%	29.13%	-1.93%	-14.48%	42.88%	14.34%	-17.58%
Net Income Q/Q Growth	-1.79%	5.95%	8.98%	-10.25%	-0.08%	20.83%	2.64%	-32.00%	48.07%	-75.06%	64.08%
EPS Q/Q Growth	0.00%	6.67%	7.14%	-7.69%	7.14%	23.08%	0.00%	-30.00%	46.15%	-71.43%	66.67%
Operating Cash Flow Q/Q Growth	-36.12%	51.13%	-106.55%	131.36%	-338.30%	70.10%	37.15%	-82.87%	151.87%	-254.44%	375.55%
Free Cash Flow Firm Q/Q Growth	-6.96%	80.27%	-59.57%	35.41%	-61.13%	11.39%	8.04%	-26.54%	60.17%	25.05%	19.47%
Invested Capital Q/Q Growth	8.29%	-1.22%	6.41%	-6.44%	20.73%	0.14%	2.79%	-0.42%	2.87%	-1.96%	-0.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.25%	54.86%	53.41%	48.91%	47.00%	55.19%	52.42%	52.89%	61.24%	62.08%	55.24%
EBITDA Margin	-64.11%	-60.34%	-53.88%	-54.01%	-49.60%	-38.35%	-31.20%	-44.85%	-20.16%	-43.46%	-3.78%
Operating Margin	-85.77%	-80.58%	-84.80%	-80.50%	-86.42%	-57.63%	-57.20%	-64.78%	-36.90%	-31.46%	-34.36%
EBIT Margin	-85.81%	-77.96%	-73.32%	-76.63%	-74.20%	-58.07%	-52.88%	-66.36%	-36.68%	-58.52%	-20.50%
Profit (Net Income) Margin	-80.95%	-71.43%	-65.35%	-70.64%	-68.62%	-51.12%	-48.47%	-63.29%	-32.78%	-57.11%	-19.06%
Tax Burden Percent	101.10%	99.84%	100.90%	101.56%	100.94%	98.59%	101.53%	102.37%	100.12%	103.22%	107.93%
Interest Burden Percent	93.31%	91.78%	88.34%	90.77%	91.62%	89.29%	90.28%	93.17%	89.26%	94.55%	86.13%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-124.74%	-66.53%	-74.75%	-73.20%	-70.36%	-48.44%	-47.65%	-57.54%	-30.31%	-26.38%	-29.15%
ROIC Less NNEP Spread (ROIC-NNEP)	-119.85%	-64.77%	-74.02%	-71.35%	-69.17%	-46.70%	-46.14%	-54.12%	-28.86%	-18.54%	-30.39%
Return on Net Nonoperating Assets (RNNOA)	85.78%	47.61%	53.89%	51.43%	46.52%	31.01%	29.43%	34.27%	16.95%	10.65%	17.11%
Return on Equity (ROE)	-38.95%	-18.92%	-20.87%	-21.77%	-23.84%	-17.43%	-18.22%	-23.28%	-13.36%	-15.72%	-12.03%
Cash Return on Invested Capital (CROIC)	-357.67%	-81.60%	-94.00%	-81.63%	-84.78%	-83.13%	-73.25%	-79.97%	-49.71%	-43.02%	-35.46%
Operating Return on Assets (OROA)	-20.15%	-18.94%	-19.67%	-21.54%	-21.82%	-17.62%	-17.28%	-22.70%	-13.19%	-21.41%	-7.69%
Return on Assets (ROA)	-19.01%	-17.36%	-17.53%	-19.85%	-20.18%	-15.51%	-15.84%	-21.65%	-11.78%	-20.89%	-7.15%
Return on Common Equity (ROCE)	-38.95%	-18.92%	-20.86%	-21.77%	-23.84%	-17.43%	-18.22%	-23.28%	-13.36%	-15.72%	-12.03%
Return on Equity Simple (ROE_SIMPLE)	-28.63%	0.00%	-27.18%	-27.89%	-27.79%	0.00%	-27.05%	-28.75%	-25.43%	0.00%	-23.95%
Net Operating Profit after Tax (NOPAT)	-30	-30	-31	-30	-34	-24	-24	-28	-16	-14	-16
NOPAT Margin	-60.04%	-56.41%	-59.36%	-56.35%	-60.49%	-40.34%	-40.04%	-45.35%	-25.83%	-22.02%	-24.05%
Net Nonoperating Expense Percent (NNEP)	-4.89%	-1.77%	-0.73%	-1.85%	-1.19%	-1.75%	-1.51%	-3.42%	-1.45%	-7.84%	1.24%
Return On Investment Capital (ROIC_SIMPLE)	-	-5.19%	-	-	-	-4.58%	-4.84%	-	-	-3.07%	-3.58%
Cost of Revenue to Revenue	49.75%	45.14%	46.59%	51.09%	53.00%	44.81%	47.58%	47.11%	38.76%	37.92%	44.76%
SG&A Expenses to Revenue	41.50%	37.03%	40.85%	38.17%	36.32%	30.41%	31.73%	34.22%	29.57%	30.78%	30.16%
R&D to Revenue	55.52%	60.09%	53.48%	49.74%	59.59%	48.27%	42.34%	44.60%	41.16%	37.29%	34.82%
Operating Expenses to Revenue	136.02%	135.44%	138.21%	129.41%	133.42%	112.82%	109.62%	117.67%	98.14%	93.55%	89.60%
Earnings before Interest and Taxes (EBIT)	-43	-41	-39	-41	-41	-34	-32	-41	-22	-36	-14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-32	-32	-28	-29	-27	-23	-19	-27	-12	-27	-2.50
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.38	2.34	2.01	1.90	1.16	1.25	0.98	1.56	1.40	4.10	2.24
Price to Tangible Book Value (P/TBV)	3.03	3.08	2.67	2.57	1.73	1.94	1.56	2.56	2.32	7.00	3.84
Price to Revenue (P/Rev)	8.08	7.04	5.50	4.91	2.87	2.95	2.15	3.13	2.68	7.41	3.97
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.87	5.62	4.20	3.97	1.47	1.71	1.00	2.34	1.89	7.63	3.69
Enterprise Value to Revenue (EV/Rev)	5.65	4.90	3.66	3.15	1.37	1.55	0.91	2.04	1.65	6.47	3.04
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	104.79
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.72	-0.74	-0.73	-0.72	-0.67	-0.66	-0.64	-0.63	-0.59	-0.57	-0.56
Leverage Ratio	1.26	1.29	1.28	1.29	1.30	1.33	1.32	1.36	1.35	1.39	1.41
Compound Leverage Factor	1.17	1.18	1.13	1.17	1.19	1.19	1.19	1.27	1.20	1.32	1.21
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.51	3.47	2.86	2.06	0.54	0.52	-0.04	0.45	0.34	3.48	0.83
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.37	3.89	3.89	3.68	2.96	2.71	2.74	2.34	2.34	2.13	2.10
Quick Ratio	4.13	3.66	3.72	3.51	2.75	2.50	2.49	2.10	2.18	1.96	1.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-199	-39	-63	-40	-65	-58	-53	-67	-27	-20	-16
Operating Cash Flow to CapEx	-1,022.39%	-735.24%	-432.52%	57.70%	-264.55%	-67.98%	-37.84%	-47.28%	45.99%	-49.26%	185.64%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.23	0.24	0.27	0.28	0.29	0.30	0.33	0.34	0.36	0.37	0.38
Accounts Receivable Turnover	6.05	4.59	6.40	6.29	5.79	5.37	5.89	5.60	5.75	4.93	4.42
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.52	1.58	1.67	1.73	1.87	1.99	1.99	2.02	2.09	2.08	2.14
Accounts Payable Turnover	37.76	19.95	11.02	33.48	29.47	22.68	12.59	36.44	26.38	40.20	29.20
Days Sales Outstanding (DSO)	60.36	79.51	56.99	58.00	63.00	68.03	62.00	65.24	63.44	74.05	82.57
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	9.67	18.30	33.14	10.90	12.39	16.09	29.00	10.02	13.83	9.08	12.50
Cash Conversion Cycle (CCC)	50.69	61.21	23.86	47.10	50.61	51.94	33.00	55.22	49.60	64.98	70.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	169	167	178	166	201	201	206	206	211	207	207
Invested Capital Turnover	2.08	1.18	1.26	1.30	1.16	1.20	1.19	1.27	1.17	1.20	1.21
Increase / (Decrease) in Invested Capital	169	9.33	31	10	32	34	29	39	11	6.49	0.20
Enterprise Value (EV)	992	938	746	659	294	343	207	480	400	1,581	762
Market Capitalization	1,417	1,347	1,122	1,027	617	650	491	739	649	1,810	994
Book Value per Share	$2.20	$2.12	$2.03	$1.95	$1.87	$1.80	$1.72	$1.63	$1.58	$1.49	$1.47
Tangible Book Value per Share	$1.73	$1.61	$1.53	$1.45	$1.25	$1.16	$1.09	$0.99	$0.95	$0.87	$0.86
Total Capital	594	576	559	540	534	518	500	473	465	441	445
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-425	-409	-376	-368	-323	-307	-284	-258	-249	-229	-233
Capital Expenditures (CapEx)	2.97	2.02	7.08	17	8.65	10	11	17	8.86	13	9.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-55	-56	-53	-56	-66	-74	-65	-71	-76	-69	-62
Debt-free Net Working Capital (DFNWC)	371	353	323	312	256	234	220	187	173	160	170
Net Working Capital (NWC)	371	353	323	312	256	234	220	187	173	160	170
Net Nonoperating Expense (NNE)	10	7.96	3.16	7.68	4.50	6.34	5.09	11	4.26	22	-3.31
Net Nonoperating Obligations (NNO)	-425	-409	-382	-373	-333	-317	-294	-268	-253	-234	-238
Total Depreciation and Amortization (D&A)	11	9.33	10	12	14	12	13	13	10	9.27	11
Debt-free, Cash-free Net Working Capital to Revenue	-31.07%	-29.22%	-26.17%	-26.86%	-30.90%	-33.42%	-28.37%	-30.17%	-31.55%	-28.04%	-24.96%
Debt-free Net Working Capital to Revenue	211.36%	184.78%	158.39%	148.99%	119.35%	105.80%	96.12%	79.34%	71.39%	65.54%	68.06%
Net Working Capital to Revenue	211.36%	184.78%	158.39%	148.99%	119.35%	105.80%	96.12%	79.34%	71.39%	65.54%	68.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.15)	($0.14)	($0.13)	($0.14)	($0.13)	($0.10)	($0.10)	($0.13)	($0.07)	($0.12)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	267.95M	267.13M	272.35M	275.05M	284.20M	279.59M	288.27M	290.36M	293.34M	292.12M	300.27M
Adjusted Diluted Earnings per Share	($0.15)	($0.14)	($0.13)	($0.14)	($0.13)	($0.10)	($0.10)	($0.13)	($0.07)	($0.12)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	267.95M	267.13M	272.35M	275.05M	284.20M	279.59M	288.27M	290.36M	293.34M	292.12M	300.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	272.10M	274.97M	276.03M	285.66M	287.63M	290.62M	290.77M	293.48M	296.71M	302.25M	303.43M
Normalized Net Operating Profit after Tax (NOPAT)	-30	-30	-31	-30	-34	-24	-24	-28	-16	-14	-16
Normalized NOPAT Margin	-60.04%	-56.41%	-59.36%	-56.35%	-60.49%	-40.34%	-40.04%	-45.35%	-25.83%	-22.02%	-24.05%
Pre Tax Income Margin	-80.07%	-71.55%	-64.77%	-69.55%	-67.98%	-51.85%	-47.73%	-61.83%	-32.74%	-55.33%	-17.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Planet Labs PBC's Financials

When does Planet Labs PBC's financial year end?

According to the most recent income statement we have on file, Planet Labs PBC's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has Planet Labs PBC's net income changed over the last 5 years?

The last 5 years of Planet Labs PBC's net income performance:

2021: -$127.10 million
2022: -$137.12 million
2023: -$161.97 million
2024: -$140.51 million
2025: -$123.20 million

Find out what analysts predict for Planet Labs PBC in the coming months.

What is Planet Labs PBC's operating income?

Planet Labs PBC's total operating income in 2025 was -$116.12 million, based on the following breakdown:

Total Gross Profit: $139.73 million
Total Operating Expenses: $255.85 million

How has Planet Labs PBC's revenue changed over the last 5 years?

Over the last 5 years, Planet Labs PBC's total revenue changed from $95.74 million in 2020 to $244.35 million in 2025, a change of 155.2%.

How much debt does Planet Labs PBC have?

Planet Labs PBC's total liabilities were at $192.51 million at the end of 2025, a 4.6% increase from 2024, and a 309,650.6% increase since 2020.

How much cash does Planet Labs PBC have?

In the past 5 years, Planet Labs PBC's cash and equivalents has ranged from $0.00 in 2020 to $490.76 million in 2022, and is currently $118.05 million as of their latest financial filing in 2025.

How has Planet Labs PBC's book value per share changed over the last 5 years?

Over the last 5 years, Planet Labs PBC's book value per share changed from 0.00 in 2020 to 1.49 in 2025, a change of 247,783.3%.

Related Companies

This page (NYSE:PL) was last updated on 6/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Planet Labs PBC (PL) Financials

Frequently Asked Questions About Planet Labs PBC's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Planet Labs PBC (PL) Financials

Annual Income Statements for Planet Labs PBC

Quarterly Income Statements for Planet Labs PBC

Annual Cash Flow Statements for Planet Labs PBC

Quarterly Cash Flow Statements for Planet Labs PBC

Annual Balance Sheets for Planet Labs PBC

Quarterly Balance Sheets for Planet Labs PBC

Annual Metrics And Ratios for Planet Labs PBC

Quarterly Metrics And Ratios for Planet Labs PBC

Frequently Asked Questions About Planet Labs PBC's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools